Indian Pharma Network – Buy prescriptions drugs

18008891064
info@indianpharmanetwork.in

Facebook Twitter Linkedin Whatsapp

Home
About Us
Product List
Blog
Support & FAQs
News
Contact Us

+91 9810469557

News

Latest News News We’re Heading to ESMO Congress 2025 in Berlin

We’re Heading to ESMO Congress 2025 in Berlin

Protect your family from dengue with Qdenga—Takeda’s breakthrough dengue vaccine, now coming to India. Stay safe with Indian Pharma Network.

FDA NEWS Latest News News

Takeda’s Qdenga Vaccine: A Breakthrough in Dengue Prevention Coming to India

Indian Company Can Manufacture Risdiplam for Spinal Muscular Atrophy (SMA)

FDA NEWS News

FDA Approves Qfitlia (Fitusiran) for Hemophilia A or B, with or without Factor Inhibitors

FDA NEWS News

FDA Approves First Treatment for a Rare Lipid Storage Disease

FDA NEWS News

FDA Approves Tenecteplase for Acute Ischemic Stroke (AIS)

FDA NEWS News

First Generic GLP-1 Injection to Treat Type 2 Diabetes is Approved by FDA

News

WHO Approves World’s First Diagnostic Test for MPox

News

FDA Approves Miplyffa: First-Ever Drug for Niemann-Pick Disease, Type C (NPC)

News

MPOX Virus Truths: Is It a Real Public Health Threat or a Hoax?

1 2 3 Next

Soliris (Eculizumab) Injection: Availability,...

Soliris (eculizumab) is a monoclonal...

FDA approval for Colorectal...

On January 19, 2023 the...

Chronic Myelomonocytic Leukemia vs...

Chronic Myelomonocytic Leukemia (CMML) and...

Stelara A Monoclonal Antibody...

Stelara (ustekinumab) is an FDA-approved...

Get to Know Your...

In the human body, adrenal...

INDIA PHARMA NETWORK

Home
About Us
News
Blog
Contact Us

TOP IMPORTED MEDICINES

Trodelvy in India
Braftovi in India
Tukysa in India
Blincyto in India
Tibsovo in India
Padcev in India

Kineret in India
Retevmo in India
Soliris in India
Zavesca in India
Zelboraf in India

CORPORATE OFFICE

Indian Pharma Network.
905-9th Floor, I-Thum Business Park,
Tower A, Plot no. A-40, Unit no. 5,
Sector-62, Noida 201301,
info@indianpharmanetwork.in

GET IN TOUCH

Indian Pharma Network facilitates patients connecting with genuine pharmaceutical suppliers, wholesalers and dealers.

Facebook Whatsapp Twitter Linkedin Pinterest

IMPORTED MEDICINES

Trodelvy in India
Braftovi in India
Tukysa in India
Blincyto in India
Tibsovo in India
Padcev in India

Kineret in India
Retevmo in India
Soliris in India
Zavesca in India
Zelboraf in India
Polivy in India

BEST TREATMENT

Muscular Dystrophy
Bladder Cancer
Brain Tumor
Cervical Cancer
Prostate Cancer
Breast Cancer

Rheumatoid Arthritis
Lung Cancer
Ovarian Cancer
Acute Myeloid Leukemia
Thyroid cancer
Kidney cancer

FDA DRUG APPROVALS 2025

Journavx
symbravo
Grafapex
Romvimza
Alhemo

Datroway
Brynovin
Gomekli
Alyftrek
Tryngolza

IMPORTED MEDICINES

Trodelvy in India
Braftovi in India
Tukysa in India
Blincyto in India
Tibsovo in India
Padcev in India

Kineret in India
Retevmo in India
Soliris in India
Zavesca in India
Zelboraf in India
Polivy in India

BEST TREATMENT

Muscular Dystrophy
Bladder Cancer
Brain Tumor
Cervical Cancer
Prostate Cancer
Breast Cancer
Colorectal Cancer

Rheumatoid Arthritis
Lung Cancer
Ovarian Cancer
Acute Myeloid Leukemia
Thyroid cancer
Kidney cancer

FDA Drug Approvals

Journavx
symbravo
Grafapex
Romvimza
Alhemo

Datroway
Brynovin
Gomekli
Alyftrek
Tryngolza

Latest News

ESMO Congress 2025 in Berlin
Takeda’s Qdenga Vaccine
Manufacture Risdiplam for (SMA)
FDA Approves Qfitlia (Fitusiran) for Hemophilia

Indian Pharma Network

Indian Pharma Network Tower A 905, I-Thum Business Park, Block A, Sector 62, Noida, Uttar Pradesh 201301

Mission Vision and value

Mobile/WhatsApp/Phone

M: +91 9654860915
M: +91 8744090915

Free Customer Support

info@indianpharmanetwork.in

Disclaimer : All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.

How can I Help You?

News

We’re Heading to ESMO Congress 2025 in Berlin

Takeda’s Qdenga Vaccine: A Breakthrough in Dengue Prevention Coming to India

Indian Company Can Manufacture Risdiplam for Spinal Muscular Atrophy (SMA)

FDA Approves Qfitlia (Fitusiran) for Hemophilia A or B, with or without Factor Inhibitors

FDA Approves First Treatment for a Rare Lipid Storage Disease

FDA Approves Tenecteplase for Acute Ischemic Stroke (AIS)

First Generic GLP-1 Injection to Treat Type 2 Diabetes is Approved by FDA

WHO Approves World’s First Diagnostic Test for MPox

FDA Approves Miplyffa: First-Ever Drug for Niemann-Pick Disease, Type C (NPC)

MPOX Virus Truths: Is It a Real Public Health Threat or a Hoax?

Related Posts

Recent Posts

INDIA PHARMA NETWORK

TOP IMPORTED MEDICINES

CORPORATE OFFICE

GET IN TOUCH

IMPORTED MEDICINES

BEST TREATMENT

TOP ARTICLES

FDA DRUG APPROVALS 2025

IMPORTED MEDICINES

BEST TREATMENT

TOP ARTICLES

FDA Drug Approvals

Latest News

Indian Pharma Network

Mobile/WhatsApp/Phone

Free Customer Support